Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 17;21(22):8671.
doi: 10.3390/ijms21228671.

Pseudomonas aeruginosa Biofilms

Affiliations
Review

Pseudomonas aeruginosa Biofilms

Minh Tam Tran Thi et al. Int J Mol Sci. .

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen causing devastating acute and chronic infections in individuals with compromised immune systems. Its highly notorious persistence in clinical settings is attributed to its ability to form antibiotic-resistant biofilms. Biofilm is an architecture built mostly by autogenic extracellular polymeric substances which function as a scaffold to encase the bacteria together on surfaces, and to protect them from environmental stresses, impedes phagocytosis and thereby conferring the capacity for colonization and long-term persistence. Here we review the current knowledge on P. aeruginosa biofilms, its development stages, and molecular mechanisms of invasion and persistence conferred by biofilms. Explosive cell lysis within bacterial biofilm to produce essential communal materials, and interspecies biofilms of P. aeruginosa and commensal Streptococcus which impedes P. aeruginosa virulence and possibly improves disease conditions will also be discussed. Recent research on diagnostics of P. aeruginosa infections will be investigated. Finally, therapeutic strategies for the treatment of P. aeruginosa biofilms along with their advantages and limitations will be compiled.

Keywords: Pseudomonas aeruginosa; biofilms; quorum sensing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Cycle of P. aeruginosa biofilm development. The development cycle is divided into six stages. Initially, the bacteria associate with the surface and produce extracellular polymeric substances (EPS) including proteins, polysaccharides, lipids and eDNA. Next, cell division and the transition of reversible attachment into irreversible take place. The following steps are the formation of microcolonies and the further development of these microcolonies into mushroom-shaped structures. Cell-to-cell interaction and production of virulence factors play essential roles in maturation and robustness of biofilms. Matrix cavity is then formed in the centre of microcolony via cell autolysis to disrupt the matrix for the liberation of the dispersed population. Finally, the released cells undergo an approximately 2 h transition into planktonic phenotypes which subsequently occupy uncolonized spaces.
Figure 2
Figure 2
Hierarchical quorum-sensing (QS) network in Pseudomonas aeruginosa. The four QS pathways are activated in response to the cell density and environmental stimuli, with four autoinducer synthases including LasI, RhlI, PqsABCDH and AmbBCDE that produce N-3-oxo-dodecanoyl-ʟ-homoserine lactone (3O-C12-HSL), N-butyryl-ʟ-homoserine lactone (C4-HSL), 2-heptyl-3-hydroxy-4-quinolone (PQS) and 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde (IQS), respectively. Note: the autoinduction is depicted in red arrows; the receptor for IQS is still unknown. The QS products are secreted through the cell membrane, that control the group behaviours and essential for the adaptation, survival and pathogenicity of P. aeruginosa. Abbreviation: CM, cytoplasmic membrane; OM, outer membrane.

Similar articles

Cited by

References

    1. Gale M.J., Maritato M.S., Chen Y.-L., Abdulateef S.S., Ruiz J.E. Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient: A mimic of malignancy. IDCases. 2015;2:40–43. doi: 10.1016/j.idcr.2015.01.004. - DOI - PMC - PubMed
    1. Wu W., Jin Y., Bai F., Jin S. Chapter 41—Pseudomonas Aeruginosa. In: Tang Y.-W., Sussman M., Liu D., Poxton I., Schwartzman J., editors. Molecular Medical Microbiology. 2nd ed. Academic Press; Cambridge, MA, USA: 2015. pp. 753–767. - DOI
    1. Gomila A., Carratalà J., Badia J.M., Camprubí D., Piriz M., Shaw E., Diaz-Brito V., Espejo E., Nicolás C., Brugués M., et al. Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: A multicenter prospective cohort study. BMC Infect. Dis. 2018;18:507. doi: 10.1186/s12879-018-3413-1. - DOI - PMC - PubMed
    1. World Health Organization . Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis. World Health Organization; Geneva, Switzerland: 2017.
    1. Pang Z., Raudonis R., Glick B.R., Lin T.J., Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol. Adv. 2019;37:177–192. doi: 10.1016/j.biotechadv.2018.11.013. - DOI - PubMed

MeSH terms

LinkOut - more resources